Exane Derivatives’s Canon, Inc. CAJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$36.2K Buy
1,596
+93
+6% +$2.25K 0.02% 333
2022
Q1
$36.5K Buy
1,503
+146
+11% +$3.5K 0.01% 603
2021
Q4
$33.1K Buy
1,357
+602
+80% +$14.2K 0.01% 546
2021
Q3
$18.4K Hold
755
﹤0.01% 686
2021
Q2
$17.3K Buy
+755
New +$17.8K ﹤0.01% 721

Other funds holding CAJ

Exane Derivatives's CAJ Position: Q2 2022 in Review

Exane Derivatives increased its Canon, Inc. (CAJ) stake by 6.2% in Q2 2022, buying an estimated $2.25K and bringing the position to 1,596 shares worth $36.2K. The position accounts for 0.02% of the portfolio, ranked #333.

Exane Derivatives first reported a position in CAJ in Q2 2021 and has held it in 5 quarters since. The position peaked at $36.5K in Q1 2022. 159 funds tracked by Wall St. Rank hold CAJ as of Q2 2022.

  • Exane Derivatives held 1,596 shares of Canon, Inc. worth $36.2K as of Q2 2022.
  • Exane Derivatives bought 93 Canon, Inc. shares in Q2 2022, an estimated $2.25K.
  • Canon, Inc. made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #333 holding.
  • Exane Derivatives first reported a position in Canon, Inc. in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Canon, Inc. position peaked at $36.5K in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Canon, Inc. as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.